Ranking the Safest Immunotherapy-Chemo Combos: Massive Analysis of 36,664 Cancer Patients Reveals Clear Winners
A network meta-analysis of 58 phase III trials covering 36,664 patients ranks the safety of 20 immune checkpoint inhibitors combined ...
A network meta-analysis of 58 phase III trials covering 36,664 patients ranks the safety of 20 immune checkpoint inhibitors combined ...
University of Sheffield researchers found that type I collagen in tumour scaffolding lets breast and pancreatic cancer cells switch fuel ...
Researchers have shown that encapsulating the anticancer compound cordycepin in solid lipid nanoparticles enhances its stability, cellular uptake, and cytotoxic ...
A retrospective cohort study of 644 children with cancer finds that apparent links between anthracycline dose and heart injury depend ...
A meta-analysis of 34 studies covering more than 10,000 premenopausal women shows that fewer than half recover ovarian function within ...
New research shows that the plant-derived arginine analogue canavanine represses ASS1 in a c-Myc-independent manner and synergizes with arginine deprivation ...
A two-year-old boy with a rare congenital portosystemic shunt and multifocal hepatoblastoma is disease-free ten months after a combined strategy ...
A study of more than 5,000 US patients with HR-positive/HER2-negative metastatic breast cancer found median survival of only 13.5 months ...
A real-world study of 526 patients found that paclitaxel liposome combined with anti-HER-2 targeted therapies delivered median overall survival of ...
Researchers have engineered EB-18, a phosphonium-substituted derivative of the classic chemotherapy drug 5-fluorouracil that outperforms 5-FU and standard agents in ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine